Header Logo

Connection

ARNOLD DELA CRUZ PAULINO to Adolescent

Back to Details
This is a "connection" page, showing publications ARNOLD DELA CRUZ PAULINO has written about Adolescent.
ARNOLD DELA CRUZ PAULINO
Connection Strength
1.757
Adolescent
  1. The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma. Neuro Oncol. 2024 Oct 03; 26(10):1912-1920.
    View in: PubMed
    Score: 0.056
  2. Late-onset lymphopenia during radiation is associated with an increased risk of tumor recurrence in newly diagnosed pediatric medulloblastoma. Pediatr Blood Cancer. 2024 Jul; 71(7):e31022.
    View in: PubMed
    Score: 0.055
  3. Comprehensive radiotherapy for pediatric Ewing Sarcoma: Outcomes of a prospective proton study. Radiother Oncol. 2024 06; 195:110270.
    View in: PubMed
    Score: 0.054
  4. Late Effects of Craniospinal Irradiation Using Electron Spinal Fields for Pediatric Patients With Cancer. Int J Radiat Oncol Biol Phys. 2023 01 01; 115(1):164-173.
    View in: PubMed
    Score: 0.048
  5. Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2021 03 01; 109(3):718-725.
    View in: PubMed
    Score: 0.044
  6. Patterns of failure following proton beam therapy for head and neck rhabdomyosarcoma. Radiother Oncol. 2019 05; 134:143-150.
    View in: PubMed
    Score: 0.038
  7. Meta-analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma. Pediatr Blood Cancer. 2018 08; 65(8):e27095.
    View in: PubMed
    Score: 0.036
  8. Radiation pneumonitis in pediatric Hodgkin lymphoma patients receiving radiation therapy to the chest. Pract Radiat Oncol. 2018 Sep - Oct; 8(5):e364-e368.
    View in: PubMed
    Score: 0.035
  9. Ototoxicity and cochlear sparing in children with medulloblastoma: Proton vs. photon radiotherapy. Radiother Oncol. 2018 07; 128(1):128-132.
    View in: PubMed
    Score: 0.035
  10. Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma. Radiother Oncol. 2015 Feb; 114(2):224-9.
    View in: PubMed
    Score: 0.029
  11. Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):858-62.
    View in: PubMed
    Score: 0.028
  12. Comparison of supine and prone craniospinal irradiation in children with medulloblastoma. Pract Radiat Oncol. 2015 Mar-Apr; 5(2):93-8.
    View in: PubMed
    Score: 0.028
  13. Stereotactic body radiation therapy (SBRT) for an isolated bone metastasis in an adolescent male with nasopharyngeal carcinoma. Pediatr Blood Cancer. 2014 Aug; 61(8):1520.
    View in: PubMed
    Score: 0.027
  14. Lymph node management in patients with paratesticular rhabdomyosarcoma: a population-based analysis. Cancer. 2013 Sep 01; 119(17):3228-33.
    View in: PubMed
    Score: 0.026
  15. Radiotherapy in metastatic ewing sarcoma. Am J Clin Oncol. 2013 Jun; 36(3):283-6.
    View in: PubMed
    Score: 0.026
  16. Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma. Cancer. 2013 Jul 15; 119(14):2654-9.
    View in: PubMed
    Score: 0.025
  17. Sinonasal teratocarcinosarcoma in an adolescent male. J Pediatr Hematol Oncol. 2012 Oct; 34(7):e304-7.
    View in: PubMed
    Score: 0.024
  18. Rhabdomyosarcoma arising in a previously irradiated field: an analysis of 43 patients. Int J Radiat Oncol Biol Phys. 2013 Mar 01; 85(3):598-603.
    View in: PubMed
    Score: 0.024
  19. Outcome of patients with pilocytic astrocytoma and leptomeningeal dissemination. Int J Radiat Oncol Biol Phys. 2012 Oct 01; 84(2):350-4.
    View in: PubMed
    Score: 0.024
  20. Impact of PET-CT on involved field radiotherapy design for pediatric Hodgkin lymphoma. Pediatr Blood Cancer. 2012 Jun; 58(6):860-4.
    View in: PubMed
    Score: 0.023
  21. Bifocal intracranial germinoma: a retrospective analysis of treatment outcomes in 20 patients and review of the literature. Int J Radiat Oncol Biol Phys. 2012 Mar 15; 82(4):1341-51.
    View in: PubMed
    Score: 0.022
  22. Characteristics and outcome of radiation and chemotherapy-related mucoepidermoid carcinoma of the salivary glands. Pediatr Blood Cancer. 2011 Dec 15; 57(7):1137-41.
    View in: PubMed
    Score: 0.022
  23. Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma. Cancer. 2011 Feb 01; 117(3):635-41.
    View in: PubMed
    Score: 0.021
  24. Height impairment after lower dose cranial irradiation in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2011 Feb; 56(2):279-81.
    View in: PubMed
    Score: 0.021
  25. Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma. Int J Radiat Oncol Biol Phys. 2010 Dec 01; 78(5):1445-50.
    View in: PubMed
    Score: 0.021
  26. Prognostic factors after extraneural metastasis of medulloblastoma. Int J Radiat Oncol Biol Phys. 2010 Sep 01; 78(1):72-8.
    View in: PubMed
    Score: 0.020
  27. Normal tissue development, homeostasis, senescence, and the sensitivity to radiation injury across the age spectrum. Semin Radiat Oncol. 2010 Jan; 20(1):12-20.
    View in: PubMed
    Score: 0.020
  28. The impact of radiotherapy fields in the treatment of patients with choroid plexus carcinoma. Int J Radiat Oncol Biol Phys. 2010 Sep 01; 78(1):79-84.
    View in: PubMed
    Score: 0.020
  29. Renal toxicity in children undergoing total body irradiation for bone marrow transplant. Radiother Oncol. 2009 Feb; 90(2):242-6.
    View in: PubMed
    Score: 0.019
  30. Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):173-7.
    View in: PubMed
    Score: 0.018
  31. Intensity-modulated radiation therapy in childhood ependymoma. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):987-93.
    View in: PubMed
    Score: 0.018
  32. Supine craniospinal irradiation using intrafractional junction shifts and field-in-field dose shaping: early experience at Methodist Hospital. Int J Radiat Oncol Biol Phys. 2008 Jun 01; 71(2):477-83.
    View in: PubMed
    Score: 0.018
  33. Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma. Pediatr Blood Cancer. 2007 Aug; 49(2):145-8.
    View in: PubMed
    Score: 0.017
  34. An analysis of primary site control and late effects according to local control modality in non-metastatic Ewing sarcoma. Pediatr Blood Cancer. 2007 Apr; 48(4):423-9.
    View in: PubMed
    Score: 0.017
  35. Collins' law revisited: can we reliably predict the time to recurrence in common pediatric tumors? Pediatr Hematol Oncol. 2006 Jan-Feb; 23(1):81-6.
    View in: PubMed
    Score: 0.015
  36. Risk factors for scoliosis in children with neuroblastoma. Int J Radiat Oncol Biol Phys. 2005 Mar 01; 61(3):865-9.
    View in: PubMed
    Score: 0.014
  37. Secondary neoplasms after radiotherapy for a childhood solid tumor. Pediatr Hematol Oncol. 2005 Mar; 22(2):89-101.
    View in: PubMed
    Score: 0.014
  38. The value of postoperative radiotherapy in childhood nonrhabdomyosarcoma soft tissue sarcoma. Pediatr Blood Cancer. 2004 Oct; 43(5):587-93.
    View in: PubMed
    Score: 0.014
  39. Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys. 2004 Sep 01; 60(1):265-74.
    View in: PubMed
    Score: 0.014
  40. Evolution of Proton Radiation Therapy Brainstem Constraints on the Pediatric Proton/Photon Consortium Registry. Pract Radiat Oncol. 2024 Nov-Dec; 14(6):e507-e514.
    View in: PubMed
    Score: 0.014
  41. Synovial sarcoma prognostic factors and patterns of failure. Am J Clin Oncol. 2004 Apr; 27(2):122-7.
    View in: PubMed
    Score: 0.014
  42. Patterns of failure in relation to radiotherapy fields in supratentorial primitive neuroectodermal tumor. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1171-6.
    View in: PubMed
    Score: 0.014
  43. Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2. Cancer. 2024 Jul 01; 130(13):2361-2371.
    View in: PubMed
    Score: 0.013
  44. Brain and Brain Stem Necrosis After Reirradiation for Recurrent Childhood Primary Central Nervous System Tumors: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys. 2024 Jun 01; 119(2):655-668.
    View in: PubMed
    Score: 0.013
  45. Brain metastasis in children with sarcoma, neuroblastoma, and Wilms' tumor. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):177-83.
    View in: PubMed
    Score: 0.013
  46. Local control of parameningeal rhabdomyosarcoma: outcomes in non-complete responders to chemoradiation. Med Pediatr Oncol. 2003 Aug; 41(2):118-22.
    View in: PubMed
    Score: 0.013
  47. Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience. J Neurooncol. 2023 Jul; 163(3):717-726.
    View in: PubMed
    Score: 0.013
  48. Multi-institutional Characterization of Outcomes for Pediatric and Young Adult Patients With High-Risk Myxopapillary Ependymoma After Radiation Therapy. Int J Radiat Oncol Biol Phys. 2023 Dec 01; 117(5):1174-1180.
    View in: PubMed
    Score: 0.013
  49. Long-term survival in a child with extraneural metastasis from medulloblastoma treated with chemo-radiotherapy. Med Pediatr Oncol. 2003 Jun; 40(6):396-7.
    View in: PubMed
    Score: 0.013
  50. Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR). J Neurooncol. 2023 Apr; 162(2):353-362.
    View in: PubMed
    Score: 0.013
  51. Palliative radiotherapy in children with neuroblastoma. Pediatr Hematol Oncol. 2003 Mar; 20(2):111-7.
    View in: PubMed
    Score: 0.013
  52. Impact of Age on Overall Survival Among Children With Wilms Tumor: A Population-based Registry Analysis. Am J Clin Oncol. 2023 05 01; 46(5):213-218.
    View in: PubMed
    Score: 0.013
  53. Protracted radiotherapy treatment duration in medulloblastoma. Am J Clin Oncol. 2003 Feb; 26(1):55-9.
    View in: PubMed
    Score: 0.013
  54. Automating the treatment planning process for 3D-conformal pediatric craniospinal irradiation therapy. Pediatr Blood Cancer. 2023 03; 70(3):e30164.
    View in: PubMed
    Score: 0.012
  55. Development and validation of a population-based anatomical colorectal model for radiation dosimetry in late effects studies of survivors of childhood cancer. Radiother Oncol. 2022 11; 176:118-126.
    View in: PubMed
    Score: 0.012
  56. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy. Int J Radiat Oncol Biol Phys. 2002 Jul 01; 53(3):543-7.
    View in: PubMed
    Score: 0.012
  57. Intracranial ependymomas: an analysis of prognostic factors and patterns of failure. Am J Clin Oncol. 2002 Apr; 25(2):117-22.
    View in: PubMed
    Score: 0.012
  58. Intensity-modulated radiation therapy in the treatment of children. Med Dosim. 2002; 27(2):115-20.
    View in: PubMed
    Score: 0.012
  59. Relapsed Wilms tumor: is there a role for radiation therapy? Am J Clin Oncol. 2001 Aug; 24(4):408-13.
    View in: PubMed
    Score: 0.011
  60. Salivary and Dental Complications in Childhood Cancer Survivors Treated With Radiation Therapy to the Head and Neck: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys. 2024 Jun 01; 119(2):467-481.
    View in: PubMed
    Score: 0.011
  61. Case series of diffuse extraneural metastasis in H3F3A mutant high-grade gliomas: Clinical, molecular phenotype and literature review. J Clin Neurosci. 2021 Jul; 89:405-411.
    View in: PubMed
    Score: 0.011
  62. Treatment age and neurocognitive outcomes following proton beam radiotherapy for pediatric low- and intermediate-grade gliomas. Pediatr Blood Cancer. 2021 08; 68(8):e29096.
    View in: PubMed
    Score: 0.011
  63. Young Adult Populations Face Yet Another Barrier to Care With Insurers: Limited Access to Proton Therapy. Int J Radiat Oncol Biol Phys. 2021 08 01; 110(5):1496-1504.
    View in: PubMed
    Score: 0.011
  64. The local field in infratentorial ependymoma: does the entire posterior fossa need to be treated? Int J Radiat Oncol Biol Phys. 2001 Mar 01; 49(3):757-61.
    View in: PubMed
    Score: 0.011
  65. Development and validation of an age-scalable cardiac model with substructures for dosimetry in late-effects studies of childhood cancer survivors. Radiother Oncol. 2020 12; 153:163-171.
    View in: PubMed
    Score: 0.011
  66. Comparison of posterior fossa and tumor bed boost in medulloblastoma. Am J Clin Oncol. 2000 Oct; 23(5):487-90.
    View in: PubMed
    Score: 0.011
  67. Early evidence of pulmonary dysfunction in survivors of childhood Hodgkin lymphoma. Leuk Lymphoma. 2020 10; 61(10):2419-2427.
    View in: PubMed
    Score: 0.010
  68. The significance of radiotherapy treatment duration in intracranial ependymoma. Int J Radiat Oncol Biol Phys. 2000 Jun 01; 47(3):585-9.
    View in: PubMed
    Score: 0.010
  69. Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis. Pediatr Blood Cancer. 2020 08; 67(8):e28373.
    View in: PubMed
    Score: 0.010
  70. A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma. Pediatr Blood Cancer. 2020 06; 67(6):e28283.
    View in: PubMed
    Score: 0.010
  71. Association of T and N Categories of the American Joint Commission on Cancer, 8th Edition, With Metastasis and Survival in Patients With Orbital Sarcoma. JAMA Ophthalmol. 2020 04 01; 138(4):374-381.
    View in: PubMed
    Score: 0.010
  72. Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study. J Clin Oncol. 2020 05 10; 38(14):1558-1568.
    View in: PubMed
    Score: 0.010
  73. Effect of sensorineural hearing loss on neurocognitive and adaptive functioning in survivors of pediatric embryonal brain tumor. J Neurooncol. 2020 Jan; 146(1):147-156.
    View in: PubMed
    Score: 0.010
  74. Superior Intellectual Outcomes After Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma. J Clin Oncol. 2020 02 10; 38(5):454-461.
    View in: PubMed
    Score: 0.010
  75. Cognitive mediators of adaptive functioning outcomes in survivors of pediatric brain tumors treated with proton radiotherapy. Pediatr Blood Cancer. 2020 02; 67(2):e28064.
    View in: PubMed
    Score: 0.010
  76. Malignant neoplasms after treatment for metachronous bilateral Wilms' tumor: a literature review. Pediatr Hematol Oncol. 1999 Nov-Dec; 16(6):533-8.
    View in: PubMed
    Score: 0.010
  77. An open invitation to join the Pediatric Proton/Photon Consortium Registry to standardize data collection in pediatric radiation oncology. Br J Radiol. 2020 Mar; 93(1107):20190673.
    View in: PubMed
    Score: 0.010
  78. Trilateral retinoblastoma: is the location of the intracranial tumor important? Cancer. 1999 Jul 01; 86(1):135-41.
    View in: PubMed
    Score: 0.010
  79. Medulloblastoma and supratentorial primitive neuroectodermal tumors: an institutional experience. Cancer. 1999 Jul 01; 86(1):142-8.
    View in: PubMed
    Score: 0.010
  80. Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only. Neuro Oncol. 2019 06 10; 21(6):809-818.
    View in: PubMed
    Score: 0.010
  81. Successful treatment of metachronous contralateral intratubular germ cell neoplasia with partial orchiectomy and low-dose radiation in a patient previously treated for testicular carcinoma. Pediatr Blood Cancer. 2019 10; 66(10):e27872.
    View in: PubMed
    Score: 0.010
  82. Adaptive functioning in pediatric brain tumor survivors: An examination of ethnicity and socioeconomic status. Pediatr Blood Cancer. 2019 09; 66(9):e27800.
    View in: PubMed
    Score: 0.010
  83. Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy. Neuro Oncol. 2019 05 06; 21(5):686-695.
    View in: PubMed
    Score: 0.010
  84. The cranial-spinal junction in medulloblastoma: does it matter? Int J Radiat Oncol Biol Phys. 1999 Apr 01; 44(1):81-4.
    View in: PubMed
    Score: 0.010
  85. A Phase 1/2 Trial of Reirradiation for Diffuse Intrinsic Pontine Glioma. Int J Radiat Oncol Biol Phys. 2019 05 01; 104(1):144-148.
    View in: PubMed
    Score: 0.009
  86. Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma. Pediatr Hematol Oncol. 2018 May; 35(4):257-267.
    View in: PubMed
    Score: 0.009
  87. Patterns of proton therapy use in pediatric cancer management in 2016: An international survey. Radiother Oncol. 2019 03; 132:155-161.
    View in: PubMed
    Score: 0.009
  88. Endocrine Deficiency As a Function of Radiation Dose to the Hypothalamus and Pituitary in Pediatric and Young Adult Patients With Brain Tumors. J Clin Oncol. 2018 10 01; 36(28):2854-2862.
    View in: PubMed
    Score: 0.009
  89. Timing of Radiation Therapy in Pediatric Wilms Tumor: A Report From the National Cancer Database. Int J Radiat Oncol Biol Phys. 2018 06 01; 101(2):453-461.
    View in: PubMed
    Score: 0.009
  90. Regional Nodal Control for Head and Neck Alveolar Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):169-176.
    View in: PubMed
    Score: 0.009
  91. Pediatric head and neck squamous cell carcinoma: Patient demographics, treatment trends and outcomes. Int J Pediatr Otorhinolaryngol. 2018 Mar; 106:21-25.
    View in: PubMed
    Score: 0.009
  92. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532. J Clin Oncol. 2018 01 20; 36(3):254-261.
    View in: PubMed
    Score: 0.009
  93. A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas. Pediatr Blood Cancer. 2018 Feb; 65(2).
    View in: PubMed
    Score: 0.009
  94. Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group. Ann Surg. 2017 09; 266(3):470-478.
    View in: PubMed
    Score: 0.009
  95. Attention, processing speed, and executive functioning in pediatric brain tumor survivors treated with proton beam radiation therapy. Radiother Oncol. 2017 07; 124(1):89-97.
    View in: PubMed
    Score: 0.008
  96. Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy. Cancer. 2017 Jul 01; 123(13):2570-2578.
    View in: PubMed
    Score: 0.008
  97. Local control in synchronous bilateral Wilms tumor. Int J Radiat Oncol Biol Phys. 1996 Oct 01; 36(3):541-8.
    View in: PubMed
    Score: 0.008
  98. Gemcitabine-induced radiation recall myositis in a patient with relapsed nasopharyngeal carcinoma. Pract Radiat Oncol. 2017 Jan - Feb; 7(1):e19-e22.
    View in: PubMed
    Score: 0.008
  99. Paediatric radiation oncology in the care of childhood cancer: A position paper by the International Paediatric Radiation Oncology Society (PROS). Radiother Oncol. 2016 05; 119(2):357-60.
    View in: PubMed
    Score: 0.008
  100. Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors. J Clin Oncol. 2016 Apr 01; 34(10):1043-9.
    View in: PubMed
    Score: 0.008
  101. Mucoepidermoid Carcinoma in Children: A Single Institutional Experience. Pediatr Blood Cancer. 2016 Jan; 63(1):27-31.
    View in: PubMed
    Score: 0.007
  102. Imaging Changes in Pediatric Intracranial Ependymoma Patients Treated With Proton Beam Radiation Therapy Compared to Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):54-63.
    View in: PubMed
    Score: 0.007
  103. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):349-57.
    View in: PubMed
    Score: 0.007
  104. Long-term outcome of centrally located low-grade glioma in children. Cancer. 2013 Jul 15; 119(14):2630-8.
    View in: PubMed
    Score: 0.006
  105. Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas. Neuro Oncol. 2013 Jun; 15(6):759-66.
    View in: PubMed
    Score: 0.006
  106. A Surveillance, Epidemiology and End Results (SEER) program comparison of adult and pediatric Wilms' tumor. Cancer. 2012 May 01; 118(9):2541-51.
    View in: PubMed
    Score: 0.006
  107. Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):214-21.
    View in: PubMed
    Score: 0.005
  108. Role of total skin electron beam therapy for leukemia cutis in pediatric patients. Pediatr Blood Cancer. 2008 May; 50(5):1054-5.
    View in: PubMed
    Score: 0.005
  109. Versatility of the Novalis system to deliver image-guided stereotactic body radiation therapy (SBRT) for various anatomical sites. Technol Cancer Res Treat. 2007 Aug; 6(4):347-54.
    View in: PubMed
    Score: 0.004
  110. A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRT. J Pediatr Hematol Oncol. 2007 Jul; 29(7):500-5.
    View in: PubMed
    Score: 0.004
  111. Scheduling for radiotherapy simulation in children with a renal mass. Pediatr Hematol Oncol. 2006 Apr-May; 23(3):275-6.
    View in: PubMed
    Score: 0.004
  112. Radiation-induced osteosarcomas in the pediatric population. Int J Radiat Oncol Biol Phys. 2005 Nov 15; 63(4):1169-74.
    View in: PubMed
    Score: 0.004
  113. Extra-target doses in children receiving multileaf collimator (MLC) based intensity modulated radiation therapy (IMRT). Pediatr Blood Cancer. 2004 Jun; 42(7):626-30.
    View in: PubMed
    Score: 0.003
  114. Locoregional treatment for adult soft tissue sarcomas of the head and neck: an institutional review. Cancer J. 2003 Jan-Feb; 9(1):49-57.
    View in: PubMed
    Score: 0.003
  115. Prognostic factors in head and neck rhabdomyosarcoma. Head Neck. 2002 May; 24(5):468-73.
    View in: PubMed
    Score: 0.003
  116. Determination of the inferior border of the thecal sac using magnetic resonance imaging: implications on radiation therapy treatment planning. Int J Radiat Oncol Biol Phys. 1998 Jun 01; 41(3):621-4.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.